Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 1,187 | 1,077 | 1,518 | 1,695 | 2,276 |
| Operating Income | -1,187 | -1,077 | -1,518 | -1,695 | -2,276 |
| Other Income | 43 | -8 | 3 | -27 | 40 |
| Pre-tax Income | -1,144 | -1,085 | -1,516 | -1,722 | -2,236 |
| Net Income Continuous | -1,144 | -1,085 | -1,516 | -1,722 | -2,236 |
| Net Income | $-1,144 | $-1,085 | $-1,516 | $-1,722 | $-2,236 |
| EPS Basic Total Ops | -0.29 | -0.29 | -0.41 | -0.48 | -0.75 |
| EPS Basic Continuous Ops | -0.30 | -0.29 | -0.40 | -0.48 | -0.74 |
| EPS Diluted Total Ops | -0.29 | -0.29 | -0.41 | -0.48 | -0.75 |
| EPS Diluted Continuous Ops | -0.30 | -0.29 | -0.40 | -0.48 | -0.74 |
| EBITDA(a) | $-1,174 | $-1,064 | $-1,505 | $-1,681 | $-2,276 |